Atopic Dermatitis Across Shades of Skin
- PMID: 37336869
- DOI: 10.1007/s40257-023-00797-1
Atopic Dermatitis Across Shades of Skin
Abstract
Atopic dermatitis (AD) is a chronic, heterogeneous inflammatory skin disease that is associated with immense patient burden globally. There is increasing appreciation of disparities among patients identified as having skin of color (SOC), which often refers to patients of non-White race or non-European ancestry, but can broadly include individuals from a number of different racial, ethnic, ancestral, and skin pigmentation groups based on definition. In this narrative review, we discuss key terminology as it relates to AD across shades of skin, including modern definitions of 'race', 'ethnicity', and 'SOC'. We then synthesize the current literature describing disparities in AD prevalence, disease recognition, and burden alongside current data regarding genetic and immunologic findings across SOC populations. In the context of these findings, we highlight key concomitant social determinants of health, including environmental factors, socioeconomic status, and access to care, for which race often serves as a proxy for true biological and genetic differences. Finally, we discuss future efforts to shift to a more inclusive understanding of AD to encompass all shades of skin, to ensure equitable representation of diverse populations in high impact research, and intensify efforts to address the critical upstream factors driving observed disparities.
© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
Special Considerations of Atopic Dermatitis in Skin of Color.Adv Exp Med Biol. 2024;1447:45-57. doi: 10.1007/978-3-031-54513-9_5. Adv Exp Med Biol. 2024. PMID: 38724783 Review.
-
Insights in Skin of Color Patients With Atopic Dermatitis and the Role of Skincare in Improving Outcomes.J Drugs Dermatol. 2022 May 1;21(5):462-470. doi: 10.36849/JDD.6609. J Drugs Dermatol. 2022. PMID: 35533036 Review.
-
Capturing the Diversity of Dermatology-What's in a Name?Am J Clin Dermatol. 2023 Sep;24(5):675-680. doi: 10.1007/s40257-023-00800-9. Epub 2023 Jun 16. Am J Clin Dermatol. 2023. PMID: 37328613
-
The Clinical Diversity of Atopic Dermatitis.Cutis. 2023 Oct;112(4):E32-E37. doi: 10.12788/cutis.0887. Cutis. 2023. PMID: 37988301 Review.
-
Reducing disparities in the care of atopic dermatitis.Arch Dermatol Res. 2024 Oct 15;316(10):688. doi: 10.1007/s00403-024-03272-x. Arch Dermatol Res. 2024. PMID: 39404903 Review.
Cited by
-
Clinical features of atopic dermatitis in pediatric patients with skin of color and comparison with different phototypes.Skin Res Technol. 2024 Feb;30(2):e13614. doi: 10.1111/srt.13614. Skin Res Technol. 2024. PMID: 38348720 Free PMC article. No abstract available.
-
Moving beyond biology: the critical role of social and structural determinants in atopic dermatitis.Int J Dermatol. 2025 Feb;64(2):272-281. doi: 10.1111/ijd.17491. Epub 2024 Sep 16. Int J Dermatol. 2025. PMID: 39282860 Free PMC article. Review.
-
Special Considerations of Atopic Dermatitis in Skin of Color.Adv Exp Med Biol. 2024;1447:45-57. doi: 10.1007/978-3-031-54513-9_5. Adv Exp Med Biol. 2024. PMID: 38724783 Review.
-
Efficacy and Safety of Lebrikizumab in Adult and Adolescent Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis: Results from the Phase IIIb, Open-Label ADmirable Study.Am J Clin Dermatol. 2025 Jul 15. doi: 10.1007/s40257-025-00970-8. Online ahead of print. Am J Clin Dermatol. 2025. PMID: 40665146
-
Phenotypes of Atopic Dermatitis and Development of Allergic Diseases.JAMA Netw Open. 2025 Jun 2;8(6):e2515094. doi: 10.1001/jamanetworkopen.2025.15094. JAMA Netw Open. 2025. PMID: 40504529 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources